Inventor

Qiuyan Zhao

Inventor
Southboro, MA, US

Overview

18→
Patents
1997–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 18 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C12NMicroorganisms or enzymes18%
C07HSugars16%
B82YSpecific uses or applications of nanostructures7%
H04LTransmission of digital information, e.g. telegraphic communication5%
G06FElectric digital data processing4%
G06QInformation and communication technology [ict] specially adapted for administrative, commercial, financial, managerial or supervisory purposes2%
PatentTitleYear
11,010,211Content processing across applications202110,999,061Service data storage method and apparatus, storage medium, and electronic device202110,977,632Electronic bill management method, apparatus, and storage medium20218,716,253'Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes'20148,476,416'Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes'20138,030,462'Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes'20117,932,367'Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes'20117,833,538'Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes'20107,824,696'Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes'20107,790,168'Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes'20107,700,570'Oligonucleotide mediated specific cytokine induction and prophylaxis and treatment of viral infection in a mammal'20107,262,286'Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes'20076,667,293'Use of cyclodextrins to modulate gene expression with reduced immunostimulatory response'20036,426,334'Oligonucleotide mediated specific cytokine induction and reduction of tumor growth in a mammal'20025,968,909'Method of modulating gene expression with reduced immunostimulatory response'19995,691,316'Cyclodextrin cellular delivery system for oligonucleotides'19975,616,565'Cyclodextrin cellular delivery system for oligonucleotides'19975,605,890'Cyclodextrin cellular delivery system for oligonucleotides'1997

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1997–2003Patents assigned to HYBRIDON INC (6)· patent assignee history
1997–2003Based in Worcester, MA, US· patent location history
2007–2014Patents assigned to IDERA PHARMACEUTICALS INC (9)· patent assignee history
2007–2014Based in Southboro, MA, US· patent location history
2013–2014Patents assigned to AGRAWAL SUDHIR (2)· patent assignee history
2013–2014Patents assigned to KANDIMALLA EKAMBAR R (2)· patent assignee history
2021Patents assigned to TENCENT TECH SHENZHEN CO LTD (2)· patent assignee history
2021Based in Shenzhen, CN· patent location history
2021Based in Beijing, CN· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
IDERA PHARMACEUTICALS INC92007–2014
HYBRIDON INC61997–2003
AGRAWAL SUDHIR22013–2014
KANDIMALLA EKAMBAR R22013–2014
TENCENT TECH SHENZHEN CO LTD22021
Locations
LocationPatentsSpan
Southboro, Massachusetts, US92007–2014
Worcester, Massachusetts, US61997–2003
Shenzhen, CN22021
Beijing, CN12021